Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q1 2025 · 10-Q
Revenue$620.39M$620.39M+53.4% vs Q1 2024 Net Income$6.69M$6.69M−54.9% vs Q1 2024 EPS Diluted$0.14$0.14−54.8% vs Q1 2024 Operating Income$20,583,000−31.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
Free Cash Flowderived$13,557,000+141.7% Margins · derivedOperating margin3.3%−4.1 pt vs Q1 2024
Net margin1.1%−2.6 pt vs Q1 2024
ended Mar 31, 2025 · filed May 9, 2025 · 39 d after period end